The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
On Nov. 27, 2006, the Animal Enterprise Terrorism Act (AETA) was officially signed into law by President George…
On Nov. 20, 2006, the Genome Sequencing Center at Washington University School of Medicine in St. Louis announced…
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
On Oct 2, 2006, National Cancer Institute researchers have linked specific genetic mutations to defects in cells that…
On Sept. 28, 2006, the Virginia Bioinformatics Institute (VBI) opened its new office complex in the National Capital…
On Sept. 27, 2006, the National Cancer Institute announced funding for a major component of its $104 million,…
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…
On Sept. 8, 2006, BD (Becton, Dickinson) announced an agreement to acquire the 93.5% of the outstanding shares…
On Sept. 6, 2006, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
On Sept. 1, 2006, National Cancer Institute researchers developed a new model for estimating the 5-year risk of…
On Aug. 23, 2006, the Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated. Designed as a national…
On Aug. 16, 2006, President Bush announced that he intended to appoint John E. Niederhuber, M.D., to be…
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…
On Jul. 20, 2006, Sandia and the University of New Mexico reported that experiments involving single-cell organisms in…
On Jul. 18, 20006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved for use in the treatment of women…
On Jun. 30, 2006, Genentech drug Lucentisï¾™ (ranibizumab injection) was approved by the FDA for the treatment of…
On Jun. 29, 2006, the Immunization Practices Advisory Committee (ACIP) recommends second dose of varicella vaccine for children.
On Jun. 29, 2006, researchers at the National Cancer Institute have identified a link between inherited and acquired…